Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19)

Conditions:   Corona Virus Infection;   Sars-CoV2 Interventions:   Dietary Supplement: Vitamins;   Drug: Hydroxychloroquine;   Drug: Imatinib;   Drug: Favipiravir;   Drug: Telmisartan Sponsors:   University Hospital, Bordeaux;   University of Bordeaux Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials